Clinical use of selected and expanded peripheral blood CD34+ cells: a preliminary report of feasibility and safety.
In this report, we describe the preliminary results from a feasibility and safety study on the clinical use of CD34-positive cells cultured from mobilized peripheral blood. Separation and cell expansion were successfully performed, and the patients tolerated the infusions without problems and achieved engraftment.
Zimmerman
T M
TM
University of Chicago Medical Center, IL 60637-1470, USA.
Williams
S F
SF
Bender
J G
JG
Lee
W J
WJ
Blake
M
M
Carreon
J
J
Swinney
P
P
Smith
S J
SJ
Schilling
M
M
Oldham
F
F
D018952:Antigens, CD34; D002469:Cell Separation; D002478:Cells, Cultured; D005260:Female; D018380:Hematopoietic Stem Cell Transplantation / Q000379:methods*; D006412:Hematopoietic Stem Cells / Q000473:pathology*; D006801:Humans
D018952:Antigens, CD34